The Leadership Team at GABA Therapeutics is responsible for strategic decision-making and overseeing the development of GRX-917. With expertise in chemistry, finance, and scientific research, they drive innovative strategies, ensure regulatory compliance, and manage resources to advance the company's mission to provide an effective and safe treatment for anxiety and depression.
View all